The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma
针对胶质母细胞瘤的 CD133 免疫疗法的合理开发
期刊:Cell Stem Cell
影响因子:19.8
doi:10.1016/j.stem.2020.04.008
Parvez Vora, Chitra Venugopal, Sabra Khalid Salim, Nazanin Tatari, David Bakhshinyan, Mohini Singh, Mathieu Seyfrid, Deepak Upreti, Stefan Rentas, Nicholas Wong, Rashida Williams, Maleeha Ahmad Qazi, Chirayu Chokshi, Avrilynn Ding, Minomi Subapanditha, Neil Savage, Sujeivan Mahendram, Emily Ford, As